Here is an all-encompassing reference tailored to the needs of research managers, chemists and biologists, clinical scientists, and executives in the pharmacology and biotechnology industry. No other resource focuses on drug discovery and pharmaceutical research from this unique perspective combining scientific and business aspects of today's biotechnology. Within every major therapeutic area, the Wiley Handbook of Current and Emerging Drug Therapies provides a general overview of the etiology and pathophsiology of the important disease indications. Then, you'll find a comprehensive analysis of currently approved drugs targeting these diseases, with information on mechanism of action, efficacy, side effects and future prospects. You'll also find product-by-product analyses of drugs currently in development, including mechanism of action, formulations, and detailed information on the status of clinical trials.
This reference also includes authoritative essays on key topics:
- The Drug Discovery Process--Overview
[Dr. Hugo Kubinyi of the University of Heidelberg] - Clinical Trials--Overview
[Dr. Curtis L. Meinert, Director of the Johns Hopkins Center for Clinical Trials]
and detailed, market-oriented analyses of:
- Emerging Technologies and Business Opportunities
- Global Markets and National Policy
- New Opportunities in Drug Discovery and Pipeline Development
Also available in a regularly-updating online version. Visit www.interscience.wiley.com/mrw/cedt for more information.
About the Author: The Handbook's content has been prepared by independent pharmaceutical market research consultants. The authorship will, however, be presented as "Wiley".
Wiley empowers learners, researchers, universities, and corporations to achieve their goals in an ever-changing world. For over 200 years, Wiley has been helping people and organizations develop the skills and knowledge they need to succeed. Wiley develops digital education, learning, assessment, and certification solutions to help universities, businesses, and individuals move between education and employment and achieve their ambitions. By partnering with learned societies, we support researchers to communicate discoveries that make a difference. Our online scientific, technical, medical, and scholarly journals, books, and other digital content build on a 200-year heritage of quality publishing.
